Bionyra Pharma Launches With $165M to Advance Immunology Biologics | Lucid Diligence Brief
Bionyra Pharma launched with $165M to advance TL1A, IL-23 and IL-25 biologics…
Immunology Today—May 13, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Public Health Today—May 8, 2026
This weekly update in public health and biomedicine highlights emerging…
Vaccines Today—April 10, 2026
This week’s Vaccines update highlights clinical progress, early-stage trial…
Immunology Today—April 8, 2026
This week’s Immunology update highlights regulatory and portfolio shifts, mid-…
AI in Healthcare and Digital Health Today—March 23, 2026
This week’s AI in Healthcare and Digital Health update highlights regulatory…
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…
ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…
Health Mobile Apps Landscape in H2 2025
Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H2…
Immunology Today—January 28, 2026
This weekly Immunology update covers late-stage clinical readouts, regulatory…
Immunology Today—January 21, 2026
This week's Immunology edition covers major regulatory milestones, late-stage…
Lucid Diligence Brief: Caldera Therapeutics launches with $112.5 million in IBD
Lucid Diligence Brief: Caldera Therapeutics launches with $112.5 million in……